NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $11.3…NASHVILLE, Tenn. (AP) — NASHVILLE, Tenn. (AP) — Insight Molecular Diagnostics Inc. (IMDX) on Monday reported a loss of $11.3 million in its second quarter. The Nashville, Tennessee-based company said it had a loss of 31 cents per share. The cancer diagnostic test developer posted revenue of $239,000 in the period. _____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDX at https://www.zacks.com/ap/IMDXCopyright © 2026 The Associated Press.